Johnson & Johnson (JNJ)
NYSE · Healthcare
$248.82-1.67%
As of Jul 20, 2026
Price history
Key statistics
- Market cap
- —
- P/E ratio
- —
- EPS
- —
- Volume
- 8,111,650
- 52-week high
- —
- 52-week low
- —
- Open
- $252.01
- Day high
- $254.18
- Day low
- $248.63
Financial highlights
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| 2025 | $94.19B | $26.8B | $11.03 |
| 2024 | $88.82B | $14.07B | $5.79 |
| 2023 | $85.16B | $35.15B | $13.72 |
| 2022 | $78.74B | $20.88B | $7.81 |
| 2021 | $82.58B | $14.71B | $5.51 |
About Johnson & Johnson
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.
- CEO
- Joaquin Duato
- Employees
- 141,700
- Country
- US
- IPO date
- Jan 2, 1962
Similar stocks
Other Healthcare companies
Frequently asked questions
- What is Johnson & Johnson's stock price today?
- JNJ is trading at $248.82 as of Jul 20, 2026.
- Does Johnson & Johnson pay a dividend?
- Yes. In FY2025, Johnson & Johnson paid $5.14 per share in dividends.
- What sector is Johnson & Johnson in?
- Johnson & Johnson operates in the Healthcare sector.